Leptin and neuropeptide Y plasma levels in children with cancer

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 5, 2005, Pages 485-489

  Çaǧlar, Kudret ^a   Kutluk, Tezer ^a   Varan, Ali ^a   Koray, Zehra ^a   Akyüz, Canan ^a   Yalçin, Bilgehan ^a   Erbaş, Belkis ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cancer cachexia; Leptin; Neuropeptide Y

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; LEPTIN; NEUROPEPTIDE Y;

ADOLESCENT; ARTICLE; BODY MASS; CACHEXIA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MALE; MEASUREMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; SEX RATIO;

EID: 18444382353     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2005.18.5.485     Document Type: Article

References (13)

1. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52: 72-91.
2. Laviano A, Russo M, Freda F, Rossi-Fanelli F. Neuro-chemical mechanisms for cancer anorexia. Nutrition 2002; 18: 100-105.
3. Inui A. Cancer anorexia-cachexia syndrome: Are neuro-peptides the key? Cancer Res 1999; 59: 4493-4501.
4. Mantovani G, Maccio A, Madeddu C, Mura L, Massa E, Mudu MC, Mulas C, Lusso MR, Gramignano G, Piras MB Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites. J Mol Med 2001; 79; 406-414.
5. Kogner P, Bjork O, Theodorsson E. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts. Med Pediatr Oncol 1993; 21: 317-322.
6. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer 2001; 92: 629-633.
7. Naveilhan P, Hassani H, Canals JM, Ekstrand AJ, Larefalk A, Chhajlani V, Arenas E, Gedda K, Svensson L, Thoren P, Ernfors P. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nature Med 1999; 5: 1188-1193.
8. Considine RV, Sinha MK Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
9. McMillan DC, Preston T, Watson WS, Simpson JM, Fearon KC, Shenkin A, Burns HJ, McArdle CS. Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer. Br J Surg 1994; 81: 1011-1014.
10. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997; 82: 4080-4082.
11. Wallace AM, Sattar N, McMillan DC. Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. Clin Cancer Res 1998; 4: 2977-2979.
12. Cohen PS, Cooper MJ, Helman LJ, Thiele CJ, Seeger RC, Israel MA. Neuropeptide Y expression in the developing adrenal gland and in childhood neuro-blastoma tumors. Cancer Res 1990; 50: 6055-6061.
13. Kirel B, Doguel N, Akgün N, Kilic FS, Tekin N, Ucar B. Serum leptin levels during childhood and adolescence: relationship with age, sex, adiposity and puberty. Turk J Pediatr 1999; 41: 447-455.